Antipsychotic Updates
The Carlat Psychiatry Report, Volume 2, Number 2, February 2004
https://www.thecarlatreport.com/newsletter-issue/tcprv2n2/
Issue Links: | Editorial Information
Topics: Antipsychotics
Daniel Carlat, MD
Dr. Carlat has disclosed that he has no significant relationships with or financial interests in any commercial companies pertaining to this educational activity.
Tired of industry-funded antipsychotic trials? The NIMH comes to the rescue with the “CATIE” project (Clinical Antipsychotic Trials of Intervention Effectiveness). Blissfully un-industry-funded researchers have enrolled 1500 schizophrenic patients at 50 different sites, and have randomly assigned them to Zyprexa, Seroquel, Risperdal, Geodon, or Trilafon (perphenazine).
You can't view details of this content, please login or buy subscription here